KAPA BAYRY kairos Pharma announces strategic collaboration with Bayer to enhance xofigo activity in metastatic prostate cancer Kairos Pharma

KAPA BAYRY kairos Pharma announces strategic collaboration with Bayer to enhance xofigo activity in metastatic prostate cancer Kairos Pharma: to evaluate Co's lead antibody env-105 with Bayer's xofigo in metastatic castration-resistant prostate cancer